Mirati Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/6/2024

Shares

365,428

Value ($000)

21,469

Weight

0.0%

2014 Q2 - 2023 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/6/2024	21,469	0.0%	365,428	12/31/2023
2023 Q3	11/8/2023	14,960	0.0%	343,442	9/30/2023
2023 Q2	8/10/2023	15,754	0.0%	436,048	6/30/2023
2023 Q1	5/12/2023	16,006	0.0%	430,494	3/31/2023
2022 Q4	2/13/2023	19,572	0.0%	431,963	12/31/2022
2022 Q3	11/14/2022	28,228	0.0%	404,174	9/30/2022
2022 Q2	8/15/2022	26,376	0.0%	392,900	6/30/2022
2022 Q1	5/13/2022	32,310	0.0%	392,958	3/31/2022
2021 Q4	2/11/2022	56,099	0.0%	382,429	12/31/2021
2021 Q3	11/16/2021	61,393	0.0%	347,025	9/30/2021
2021 Q2	8/16/2021	55,287	0.0%	342,268	6/30/2021
2021 Q1	5/17/2021	71,398	0.0%	416,798	3/31/2021
2020 Q4	2/16/2021	89,100	0.0%	405,663	12/31/2020
2020 Q3	11/13/2020	57,840	0.0%	348,328	9/30/2020
2020 Q2	8/20/2020	29,828	0.0%	261,255	6/30/2020
2020 Q1	5/15/2020	17,537	0.0%	228,136	3/31/2020
2019 Q4	2/7/2020	25,135	0.0%	195,051	12/31/2019
2014 Q2	7/30/2014	210	0.0%	10,500	6/30/2014